BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638
5052 results:

  • 1. Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.
    Carlund O; Thörn E; Osterman P; Fors M; Dernstedt A; Forsell MNE; Erlanson M; Landfors M; Degerman S; Hultdin M
    Clin Epigenetics; 2024 May; 16(1):68. PubMed ID: 38773655
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-chop chemotherapy.
    Kwak K; Park Y; Kim BS; Kang KW
    Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Diffuse Large B-Cell lymphoma With Cardiac Invasion Presented as Acute Myocardial Infarction and Left Ventricular Hypertrophy: A Case Report.
    Liu Z; Pan X; Mo J; Deng T; Cen T; Wei B; Chen C
    J Investig Med High Impact Case Rep; 2024; 12():23247096241253334. PubMed ID: 38747509
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Digital Gangrene as a Paraneoplastic Manifestation of Peripheral T-cell lymphoma Not Otherwise Specified Type.
    Madhuram GS; Geetha T; Bharathiraja G; Arunkumar P; Prabagar M; Subramaniam K
    J Assoc Physicians India; 2024 Jan; 72(1):99-102. PubMed ID: 38736082
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
    Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
    [No Abstract]    [Full Text] [Related]  

  • 6. Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma.
    Gatwood J; Masaquel A; Fox D; Sheinson D; James C; Li J; Hossain F; Ross R
    J Med Econ; 2024; 27(1):738-745. PubMed ID: 38686393
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Impact of Tumor Hypoxia Modulation on sIL-2R Levels in Newly Diagnosed Diffuse Large B Cell lymphoma (DLBCL) Patients Undergoing Chemotherapy: A Randomized Clinical Trial.
    Rizky D; Tandarto K; Pangarsa EA; Naibaho RM; Kurniawan SP; Santosa D; Setiawan B; Suharti C
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1315-1324. PubMed ID: 38679992
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
    Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
    Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell lymphoma: Insights into Treatment Outcomes.
    Xie Z; Qin Y; Chen X; Yang S; Yang J; Gui L; Liu P; He X; Zhou S; Zhang C; Tang L; Shi Y
    Target Oncol; 2024 May; 19(3):383-400. PubMed ID: 38643457
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathologic analysis of nodal T-follicular helper cell lymphomas, a multicenter retrospective study from China.
    Ma S; Li S; Zuo X; Li W; Wang L; Liu W; Wang Z; Sang W; Wang Y; Zhang X; Zhang M
    Front Immunol; 2024; 15():1371534. PubMed ID: 38601148
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy.
    Sineshaw HM; Zettler CM; Prescott J; Garg M; Chakraborty S; Sarpong EM; Bai C; Belli AJ; Fernandes LL; Wang CK
    Cancer Med; 2024 Apr; 13(7):e7173. PubMed ID: 38597118
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
    Watanabe T; Matsuno Y; Wakabayashi M; Maruyama D; Yamamoto K; Kubota N; Shimada K; Asagoe K; Yamaguchi M; Ando K; Ogura M; Kuroda J; Suehiro Y; Tsukasaki K; Tobinai K; Nagai H
    Hematol Oncol; 2024 May; 42(3):e3272. PubMed ID: 38595316
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
    Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prediction of immunochemotherapy response for diffuse large B-cell lymphoma using artificial intelligence digital pathology.
    Lee JH; Song GY; Lee J; Kang SR; Moon KM; Choi YD; Shen J; Noh MG; Yang DH
    J Pathol Clin Res; 2024 May; 10(3):e12370. PubMed ID: 38584594
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Case of CD4 + T-Cell lymphoma With Gamma-Delta Phenotype, Incidentally Manifesting in a Wound Debridement Sample.
    Adams PE; Ehyayee V; Ahmed A
    Am J Dermatopathol; 2024 Jun; 46(6):383-385. PubMed ID: 38574061
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Successful bridging therapy with alectinib prior to allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma].
    Kono A; Tanaka K; Shimada T; Bando K; Takahata A; Koi S; Yamamoto M; Mori T; Toyota S
    Rinsho Ketsueki; 2024; 65(3):158-163. PubMed ID: 38569859
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acute kidney failure reveals primary renal non-Hodgkin lymphoma.
    Klaus M; Sitter T; Hoppe JM
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569735
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
    Hampel PJ; Swaminathan M; Rogers KA; Parry EM; Burger JA; Davids MS; Ding W; Ferrajoli A; Hyak JM; Jain N; Kenderian SS; Wang Y; Wierda WG; Woyach JA; Parikh SA; Thompson PA
    Blood Adv; 2024 May; 8(10):2342-2350. PubMed ID: 38537065
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary adrenal lymphoma presenting as neurolymphomatosis: A case report.
    Chen Z; Lin L; Xu L; Lin R; Jiang X
    Medicine (Baltimore); 2024 Mar; 103(12):e37558. PubMed ID: 38518055
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 253.